Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-01-27 @ 7:55 AM
Study NCT ID:
NCT00692159
Status:
COMPLETED
Last Update Posted:
2010-09-10
First Post:
2008-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of TRC102 in Combination With Pemetrexed in Cancer Patients
Sponsor:
Tracon Pharmaceuticals Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neoplasm | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | TRC102 | View |
| None | Methoxyamine HCL | View |
| None | Pemetrexed | View |
| None | Alimta | View |
| None | Tracon | View |
| None | Phase 1 | View |
| None | Cancer | View |
| None | BER | View |
| None | Base Excision Repair | View |
| None | Small Molecule | View |
| None | Anti-folate | View |
| None | Solid Tumor | View |
| None | Neoplastic Processes | View |
| None | Pathologic Processes | View |
| None | Pathological Conditions, Signs and Symptoms | View |